Grifols SA GRFS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:56 AM EDT
6.57quote price arrow down-0.08 (-1.28%)
Volume
89,816
52 week range
5.30 - 12.15
Loading...
  • Open6.58
  • Day High6.59
  • Day Low6.54
  • Prev Close6.65
  • 52 Week High12.15
  • 52 Week High Date12/29/23
  • 52 Week Low5.30
  • 52 Week Low Date03/06/24

Key Stats

  • Market Cap4.514B
  • Shares Out687.55M
  • 10 Day Average Volume2.70M
  • Dividend0.66
  • Dividend Yield10.02%
  • Beta0.55
  • YTD % Change-43.34

KEY STATS

  • Open6.58
  • Day High6.59
  • Day Low6.54
  • Prev Close6.65
  • 52 Week High12.15
  • 52 Week High Date12/29/23
  • 52 Week Low5.30
  • 52 Week Low Date03/06/24
  • Market Cap4.514B
  • Shares Out687.55M
  • 10 Day Average Volume2.70M
  • Dividend0.66
  • Dividend Yield10.02%
  • Beta0.55
  • YTD % Change-43.34

RATIOS/PROFITABILITY

  • EPS (TTM)0.10
  • P/E (TTM)65.98
  • Fwd P/E (NTM)7.78
  • EBITDA (TTM)1.275B
  • ROE (TTM)0.99%
  • Revenue (TTM)7.136B
  • Gross Margin (TTM)37.84%
  • Net Margin (TTM)2.74%
  • Debt To Equity (MRQ)173.63%

EVENTS

  • Earnings Date05/07/2024(est)
  • Ex Div Date06/03/2021
  • Div Amount0.4566
  • Split Date-
  • Split Factor-

Latest On Grifols SA

Profile

MORE
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing...
Thomas Glanzmann
Chairman, Executive Director
Jose Ignacio Abia
Chief Executive Officer, Executive Director
Alfredo Arroyo Guerra
Chief Financial Officer
Miguel Angel Louzan Garcia
Chief Digital Information Officer
Francisco Javier Guix Huguet
Vice President - Healthcare Solutions
Address
C/ Jesus y Maria, 6
Barcelona, BAR
08022
Spain

Top Peers

SYMBOLLASTCHG%CHG
CRL
Charles River Laboratories International Inc
268.81-0.56-0.21%
INCY
Incyte Corp
56.84-0.27-0.48%
EXEL
Exelixis Inc
23.87+0.01+0.04%
PTCT
PTC Therapeutics Inc
29.33-0.11-0.37%
EXAS
Exact Sciences Corp
68.72+1.84+2.75%